Results 111 to 120 of about 4,569 (190)

The genetic architecture of leaf vein density and its importance for photosynthesis in maize

New Phytologist, Volume 251, Issue 4, Page 1738-1754, August 2026.
Vein types in maize leaves. Summary Leaf venation density has significantly increased during plant evolution. Higher densities are observed in angiosperms compared with early land plants, and among angiosperms, recently diverged C4 species have the highest values.
José Luis Coyac‐Rodríguez, Sergio Pérez‐Limón, Elizabeth Hernández‐Jaimes, Marcela Hernández‐Coronado, Daniel Camo‐Escobar, Ana Laura Alonso‐Nieves, María de Jesús Ortega‐Estrada, Nicole Gómez‐Capetillo, Ruairidh J. H. Sawers, Carlos Ortiz‐Ramírez   +9 more
wiley   +1 more source

Effectiveness and Safety of Radium-223 for Bone-Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study. [PDF]

Cancer Sci
Shiota M, Tatarano S, Kamba T, Kamoto T, Igawa T, Masumori N, Uemura H, Mitsunari K, Sumiyoshi T, Uemura H, Higashijima K, Tokunaga S, Eto M.   +12 more
europepmc   +1 more source

UK real-world data of radium-223 dichloride in metastatic prostate cancer. [PDF]

Nucl Med Commun
Randhawa M, Buchanan G, Stratton IM, Race G, Challapalli A, Bottomley D, Logue J, Sundar S, Robinson A, Mclaren DB, Stevenson R, O'Sullivan JM, Sweeney L, McGrane J, Jiang X, Mazhar D, Khoo V, McPhail N, Jones RJ, National Radium-223 Dichloride Audit Group.   +19 more
europepmc   +1 more source

Cancer-control outcomes of Radium- 223-pretreated lutetium- 177-PSMA Radioligand vs. Radium- 223-naïve mCRPC patients. [PDF]

Eur J Nucl Med Mol Imaging
Wenzel M, Theissen L, Groener D, Kriegmair M, Graefen M, Maurer T, Salomon G, Hoeh B, Siech C, Banek S, Chun FKH, Mandel P.   +11 more
europepmc   +1 more source

Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases. [PDF]

Precis Oncol
Lilieholm C, Adeniyi AO, Kwon O, Zaborek J, Kerr CP, Rojas HC, Idrissou MB, Ferreira CA, Clark PA, Clark PA, Jin WJ, Grudzinski JJ, Erbe AK, Hernandez R, Bednarz B, Morris ZS, Weichert JP.   +16 more
europepmc   +1 more source

Prostate cancer – Therapy with radium-223 [PDF]

Revista da Associação Médica Brasileira, 2017
Ana Emília, Brito, Bárbara Juarez, Amorim, Milena, Martello, Wanderley Marques, Bernardo, Elba, Etchebehere   +4 more
openaire   +2 more sources

Reply to: Revisiting Radium-223 in Oligometastatic Castration-Sensitive Prostate Cancer: RAVENS Trial Insights. [PDF]

J Clin Oncol
Tran PT, Wang JH, Tang C, Kiess AP.
europepmc   +1 more source

Fracture risk and survival outcomes of radium-223 therapy for bone metastases in mCRPC and the modulatory role of bone-protective therapy: a systematic review and meta-analysis. [PDF]

Front Oncol
Xiao M, Liu F, Duan H.
europepmc   +1 more source

Impact of timing of radium‑223 administration on the survival of patients with bone metastatic castration‑resistant prostate cancer. [PDF]

Med Int (Lond), 2023
Makita K, Hamamoto Y, Kanzaki H, Yamashita N, Nagasaki K, Kido T, Miura N, Saika T, Hashine K.   +8 more
europepmc   +1 more source

Exhalation of Rn-219 by patients treated with Radium-223. [PDF]

EJNMMI Phys
Wanke C, Pinkert J, Geworski L, Szermerski B.   +3 more
europepmc   +1 more source